Surveillance of SARS-CoV-2 antibodies of patients in the local affected area during Wuhan lockdown

Highlights 1. Two months after the COVID-19 outbreak in Wuhan, the seroprevalence for IgM and IgG in the convalescent patients was 31.82% and 77.27%, respectively. In the total outpatient population, the mean seroprevalence for IgM and IgG in all participants was 2.81% and 7.51%, respectively. 2. Se...

Full description

Bibliographic Details
Main Authors: Yueting Tang, Jiayu Sun, Yumeng Yuan, Fen Yao, Bokun Zheng, Gui Yang, Wen Xie, Guangming Ye, Zhen Li, Xiaoyang Jiao, Yirong Li
Format: Article
Language:English
Published: BMC 2022-01-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-021-07010-w
Description
Summary:Highlights 1. Two months after the COVID-19 outbreak in Wuhan, the seroprevalence for IgM and IgG in the convalescent patients was 31.82% and 77.27%, respectively. In the total outpatient population, the mean seroprevalence for IgM and IgG in all participants was 2.81% and 7.51%, respectively. 2. Seroprevalence for IgG in medical staff was markedly higher than those in residents. 3. The seroprevalence for IgG was significantly higher in women and elderly individuals than those in men and younger individuals. Individuals with comorbidity had higher seroprevalence than those without comorbidity.
ISSN:1471-2334